Candel Therapeutics, Inc.
CADL· Nasdaq
Released Aug 14, 2025, before the open
10-Q filed Aug 14, 2025, 45 days after period end · 0000950170-25-108450
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | — | — | — | $31.00K |
| Net Income | -$4.80M | -$22.24M | -$9.61M | -$4.15M |
| EPS Diluted |
Candel Therapeutics, Inc. · CIK 1841387 · Engraved from SEC EDGAR
| -$0.09 |
| -$0.74 |
| -$0.33 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.